Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial.

Inman, Robert D   •   Davis, John C Jr   •   Heijde, Desiree van der   •   Diekman, Laura   •   Sieper, Joachim   •   Kim, Sung Il   •   Mack, Michael   •   Han, John   •   Visvanathan, Sudha   •   Xu, Zhenhua   •   Hsu, Benjamin   •   Beutler, Anna   •   Braun, Jurgen

published in: Arthritis and rheumatism



endpoint

Golimumab has (optional: compared with placebo) proved to be better.
complication rate equal


basics

diagnosis:
ankylosing spondylitis

localization:
not specified

method:
conservative therapy → injection
conservative therapy → injection therapy
conservative therapy → injection therapy

publication details

10.1002/art.23969
pubmed
18975305
2008
randomized controlled trial
yes
prospective
1+